Ketogenic diet may improve efficacy of cancer drugs
A study, published in the journal Nature, found a strategy to boost the tumour-killing potential of therapies targeted on the insulin-activated enzyme, phosphatidylinositol-3 kinase (PI3K) – a family of enzymes involved in cellular functions such as cell growth, proliferation and differentiation. “Any drug that targets PI3K may not be effective unless patients can maintain low … Read more
